Great-West Lifeco Inc. Share Price Deutsche Boerse AG

Equities

GWS

CA39138C1068

Life & Health Insurance

Market Closed - Deutsche Boerse AG 11:31:18 07/06/2024 am IST 5-day change 1st Jan Change
26.6 EUR -0.75% Intraday chart for Great-West Lifeco Inc. -4.32% -10.14%

Financials

Sales 2024 * 6.77TCr 4.91TCr 4.55TCr 4,10600Cr Sales 2025 * 6.99TCr 5.07TCr 4.7TCr 4,23900Cr Capitalization 3.72TCr 2.7TCr 2.5TCr 2,25900Cr
Net income 2024 * 387.3Cr 281.18Cr 260.56Cr 23TCr Net income 2025 * 407.4Cr 295.77Cr 274.08Cr 25TCr EV / Sales 2024 * 0.55 x
Net cash position 2024 * - 0 0 0 Net cash position 2025 * - 0 0 0 EV / Sales 2025 * 0.53 x
P/E ratio 2024 *
9.6 x
P/E ratio 2025 *
9.01 x
Employees 33,500
Yield 2024 *
5.57%
Yield 2025 *
5.86%
Free-Float 26.33%
More Fundamentals * Assessed data
Dynamic Chart
Great-West Lifeco Brief: Adds common shares do not trade on a recognized stock exchange in the United States MT
Great-West Lifeco Brief: Says Unsolicited offer represents a discount of Near 34.42% to Closing price of the common shares on TSX on May 17, 2024, the last trading day before the offer was commenced MT
Great-West Lifeco Brief: Notes Offer Is To Purchase up to 50,000 common shares of Lifeco MT
Great-West Lifeco Brief: Cautioning investors regarding New York Stock and Bond LLC's mini-tender offer for shares in the United States MT
Great-West Lifeco Inc. Appoints Shubha Khan as SVP, Head of Investor Relations, Effective June 3 CI
Power Corp. of Canada, Great-West Lifeco Ratings Affirmed at S&P MT
Great-West Lifeco Takes Minority Stake in Power Sustainable Manager MT
Power Sustainable Manager Inc. and Great-West Lifeco Inc. Announce Strategic Partnership CI
Power Corp.'s Sustainable-investing Arm Gains Familiar New Shareholder MT
Great-West Lifeco Inc. Approves Board Election CI
Transcript : Great-West Lifeco Inc., Q1 2024 Earnings Call, May 02, 2024
National Bank's Takeaways From Great West Lifeco's Q1 Results MT
Transcript : Great-West Lifeco Inc. - Shareholder/Analyst Call
Great-West Lifeco Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Great-West Lifeco Brief: Q1 Net earnings from continuing operations of $1,031 million or $1.10 per share, up 68% from a year ago MT
More news
1 day-0.75%
1 week-4.32%
Current month-4.32%
1 month-8.28%
3 months-10.14%
6 months-10.74%
Current year-10.14%
More quotes
1 week
26.60
Extreme 26.6
28.00
1 month
26.60
Extreme 26.6
29.40
Current year
26.60
Extreme 26.6
31.00
1 year
25.40
Extreme 25.4
31.00
3 years
20.60
Extreme 20.6
31.00
5 years
12.40
Extreme 12.4
31.00
10 years
12.40
Extreme 12.4
31.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 60 01/13/01
Director of Finance/CFO - 05/23/05
Chief Investment Officer - 01/17/01
Members of the board TitleAgeSince
Director/Board Member 68 22/92/22
Director/Board Member 69 15/86/15
Director/Board Member 67 08/14/08
More insiders
Date Price Change
07/24/07 26.6 -0.75%
06/24/06 26.8 -4.29%
05/24/05 28 +2.19%
04/24/04 27.4 -0.72%
03/24/03 27.6 -0.72%

Delayed Quote Deutsche Boerse AG, June 07, 2024 at 11:31 am IST

More quotes
Great-West Lifeco Inc. is an international financial services holding company. The Company has interests in life insurance, health insurance, retirement and investment services, asset management and reinsurance businesses. Its segments include Canada, United States, Europe, and Capital and Risk Solutions. It operates in Canada, the United States and Europe under the brands Canada Life, Empower, and Irish Life. It operates through its subsidiaries, including The Canada Life Assurance Company (Canada Life), and Empower Annuity Insurance Company of America (Empower). Canada Life provides insurance and wealth management products and services in Canada, the United Kingdom, the Isle of Man and Germany, and in Ireland through Irish Life. Empower provides retirement plans.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
10
Last Close Price
39.92 CAD
Average target price
44.1 CAD
Spread / Average Target
+10.47%
Consensus